The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, L.
Right arrow Articles by Fanger, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, L.
Right arrow Articles by Fanger, M. W.

The Journal of Immunology, Vol 137, Issue 11 3378-3382, Copyright © 1986 by American Association of Immunologists

ARTICLES

Heteroantibody-mediated cytotoxicity: antibody to the high affinity Fc receptor for IgG mediates cytotoxicity by human monocytes that is enhanced by interferon-gamma and is not blocked by human IgG

L Shen, PM Guyre, CL Anderson and MW Fanger

An IgG1 monoclonal antibody, 32.2, raised against the 72,000 dalton monocyte high affinity Fc receptor, was used to examine the role of this receptor in ADCC. This antibody did not inhibit the binding of human IgG1 to monocytes or to the U937 cell line, nor did it block or stimulate their killing of IgG-coated chicken erythrocytes (CE). Whole 32.2 or its Fab fragments were cross-linked to Fab fragments of rabbit anti-CE by using the agent SPDP. The resulting heteroantibodies (32.2 X Fab anti-CE) mediated monocyte and U937 cytotoxicity against CE, whereas an anti-HLA X anti-CE reagent did not. Both FcR expression and heteroantibody-mediated cytotoxicity were increased by culturing monocytes or U937 with IFN-gamma. Although IgG-mediated ADCC was significantly inhibited by 40 micrograms/ml human IgG1, cytotoxicity mediated by 32.2 X Fab anti-CE was not blocked by 2 mg/ml human IgG1, suggesting that such cytotoxicity might not be blocked by IgG in vivo. These data indicate the potential of 32.2 heteroantibodies in analysis of FcR function and in therapy.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
L. S. Shahied, Y. Tang, R. K. Alpaugh, R. Somer, D. Greenspon, and L. M. Weiner
Bispecific Minibodies Targeting HER2/neu and CD16 Exhibit Improved Tumor Lysis When Placed in a Divalent Tumor Antigen Binding Format
J. Biol. Chem., December 24, 2004; 279(52): 53907 - 53914.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. M. McCall, L. Shahied, A. R. Amoroso, E. M. Horak, H. H. Simmons, U. Nielson, G. P. Adams, R. Schier, J. D. Marks, and L. M. Weiner
Increasing the Affinity for Tumor Antigen Enhances Bispecific Antibody Cytotoxicity
J. Immunol., May 15, 2001; 166(10): 6112 - 6117.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. C. Pfefferkorn, J. G. J. van de Winkel, and S. L. Swink
A Novel Role for IgG-Fc
J. Biol. Chem., April 7, 1995; 270(14): 8164 - 8171.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
J. Prins, J. Todd, N. Rodrigues, S Ghosh, P. Hogarth, L. Wicker, E Gaffney, P. Podolin, P. Fischer, A Sirotina, et al.
Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice
Science, April 30, 1993; 260(5108): 695 - 698.
[Abstract] [PDF]

Home page
 ScienceHome page
M. Liu, Nussbaum SR, and H. Eisen
Hormone conjugated with antibody to CD3 mediates cytotoxic T cell lysis of human melanoma cells
Science, January 22, 1988; 239(4838): 395 - 398.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1986 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1986 by The American Association of Immunologists, Inc. All rights reserved.